Bucciarelli, Valentina Nasi, Milena Bianco, Francesco Seferovic, Jelena Ivkovic, Vladimir Gallina, Sabina Mattioli, Anna Vittoria
Published in
Trends in Cardiovascular Medicine
The ongoing COVID-19 pandemic highlighted a significant interplay between cardiovascular disease (CVD), COVID-19 related inflammatory status, and depression. Cardiovascular (CV) injury is responsible for a substantial percentage of COVID-19 deaths while COVID-19 social restrictions emerged as a non-negligible risk factor for CVD as well as a variet...
Chew, Christine Reynolds, John A Lertratanakul, Apinya Wu, Peggy Urowitz, Murray Gladman, Dafna D Fortin, Paul R Bae, Sang-Cheol Gordon, Caroline Clarke, Ann E
...
Published in
Rheumatology (Oxford, England)
Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance. The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently ...
Wang, Wenqiang He, Jia Hu, Yunhua Song, Yanpeng Zhang, Xianghui Guo, Heng Wang, Xinping Keerman, Mulatibieke Ma, Jiaolong Yan, Yizhong
...
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Background We aimed to identify the relationship between metabolically healthy obesity (MHO), a special subtype of obesity, and the incidence of cardiovascular disease (CVD) in rural Xinjiang. Methods Body mass index (BMI) and the Joint Interim Statement criteria were utilized to define obesity and metabolic status, respectively. A baseline survey ...
Murray, Margaret Dordevic, Aimee L Cox, Kate Scholey, Andrew Ryan, Lisa Bonham, Maxine P
Published in
The Journal of nutritional biochemistry
Cardiovascular diseases (CVD) are the leading global cause of death. Strategies to reduce CVD risk are urgently needed. Polyphenols represent a class of bioactive compounds with potential to moderate biochemical risk factors for CVD (cholesterol, triglycerides, glucose, and inflammation). This double-blind, placebo-controlled, randomized parallel-g...
Pirih, Flavia Q Monajemzadeh, Sepehr Singh, Neelima Sinacola, Rachel Sheridan Shin, Jae Min Chen, Tsute Fenno, J Christopher Kamarajan, Pachiyappan Rickard, Alexander H Travan, Suncica
...
Periodontitis has been associated with many systemic diseases and conditions, including metabolic syndrome. Metabolic syndrome is a cluster of conditions that occur concomitantly and together they increase the risk of cardiovascular disease and double the risk of type 2 diabetes. In this review, we focus on the association between metabolic syndrom...
Peeri, Noah C Chai, Weiwen Cooney, Robert V Tao, Meng-Hua
Published in
Public health nutrition
To examine associations between serum antioxidant levels and mortality (all-cause, cancer and CVD) among US adults. We examined the risk of death from all-cause and cause-specific mortality associated with serum antioxidant (vitamin E and carotenoids) and vitamin A levels using Cox regression models to estimate hazards ratios (HR) and 95 % CI. The ...
Dinh, Quynh Nhu Vinh, Antony Arumugam, Thiruma V Drummond, Grant R Sobey, Christopher G
Published in
British journal of pharmacology
As an agonist of the classical nuclear receptors, estrogen receptor-α and -β (NR3A1/2), estrogen has been assumed to inhibit the development of cardiovascular disease in premenopausal women. Indeed, reduced levels of estrogen after menopause are believed to contribute to accelerated morbidity and mortality rates in women. However, estrogen replacem...
Wang, Xiaofeng Wang, Qi Wei, Donghui Chang, Xiaolong
Published in
Canadian journal of diabetes
The soluble receptor for advanced glycation end product (sRAGE) and endogenous secretory RAGE (esRAGE) are novel biomarkers that are associated with vascular disease. We carried out a systematic review to provide a more complete picture of sRAGE, esRAGE, carotid atherosclerosis and cardiovascular disease (CVD) in patients with diabetes. We searched...
Mousa, Rimal Hammad, Eman
Published in
Expert review of pharmacoeconomics & outcomes research
Cardiovascular diseases (CVDs) are responsible for one third of global deaths and the main cause of death among Jordanians. Pharmacist-led care was outlined previously as a cost-effective approach in the management of chronic illness; however, this is not well studied in low to middle-income countries. To assess the cost-effectiveness of pharmacist...
Ren, Jun Wu, Ne N Wang, Shuyi Sowers, James R Zhang, Yingmei
Published in
Physiological reviews
The prevalence of heart failure is on the rise and imposes a major health threat, in part, due to the rapidly increased prevalence of overweight and obesity. To this point, epidemiological, clinical, and experimental evidence supports the existence of a unique disease entity termed "obesity cardiomyopathy," which develops independent of hypertensio...
